Skip to main content

Bacterial Infection News (Page 7)

Related terms: Infection, Bacterial

Aqua Pharmaceuticals Announces FDA Approval of Acticlate (doxycycline hyclate USP) Tablets

West Chester, Pa. — July 28, 2014 West Chester-based Aqua Pharmaceuticals, an Almirall company, today announces the U.S. Food and Drug Administration (FDA) approval of the NDA for Acticlate (...

FDA Medwatch Alert: Cefepime For Injection, USP And Dextrose Injection, USP By B. Braun Medical Inc.: Recall - Visible Particulate Matter

ISSUE: B. Braun Medical Inc. is voluntarily recalling one lot of 1g Cefepime for Injection USP and Dextrose Injection USP (Lot H3A744, catalog 3193-11) to the consumer level. The 1g Cefepime for ...

FDA Medwatch Alert: Cubicin (daptomycin for injection): Recall - Glass Particulate Matter Present in Four Lots

ISSUE: Cubist has notified customers by letter and phone of the voluntary recall of four lots of Cubicin (daptomycin for injection) due to the presence of particulate matter found in a number of...

FDA Medwatch Alert: Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution

ISSUE: Apotex Corp. notified healthcare professionals it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 15 lots of Piperacillin and Tazobactam for...

FDA Medwatch Alert: Benzalkonium Chloride Antiseptic Wipes by Dukal: Recall - Potential Microbial Contamination

ISSUE: Dukal Corporation announced a U.S. voluntary nationwide recall of selected lots of benzalkonium chloride swabs and antiseptic wipes manufactured for Dukal by Jianerkang Medical Dressing Co....

FDA Medwatch Alert: Cefepime:Label Change- Risk of Seizure in Patients Not Receiving Dosage Adjustments for Kidney Impairment

[Posted 6/26/2012] Issue: There have been cases of a specific type of seizure called nonconvulsive status epilepticus associated with the use of cefepime, primarily in patients with renal impairment...

FDA Medwatch Alert: Zithromax (azithromycin): FDA Statement on risk of cardiovascular death

ISSUE: FDA notified healthcare professionals that it is aware of the study published in the New England Journal of Medicine  May 17, 2012 reporting a small increase in cardiovascular deaths, and in t...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Bacterial Skin Infection, Skin and Structure Infection, Bacterial Vaginitis, Lyme Disease, Methicillin-Resistant Staphylococcus Aureus Infection, Infections

Related drug support groups

amoxicillin, metronidazole, doxycycline, cephalexin, clindamycin, azithromycin, Bactrim, Cipro, Zithromax, view more... ciprofloxacin, Keflex, Flagyl, Levaquin, Augmentin, levofloxacin, sulfamethoxazole, sulfamethoxazole / trimethoprim, vancomycin, amoxicillin / clavulanate, cefdinir, Bactrim DS, tetracycline, Rocephin, garlic